Exploring the Future of Pharma: AI and Digital Twin Technologies
The AUTOMA+ 2025 conference held in Vösendorf, Austria, on November 24–25, signified a pivotal moment for the pharmaceutical and technology sectors as they converge to redefine industry standards. Leaders from renowned companies such as Merck, GSK, and Boehringer Ingelheim gathered to discuss impressive strides in digital research and development, lab automation, and smart manufacturing processes that leverage cutting-edge technologies like AI and digital twins.
Why Digital Skills Are Essential in Pharma
As the reliance on technology grows, building digital skills within pharmaceutical organizations has never been more critical. During the first day of the congress, experts emphasized the importance of bridging the knowledge gap through training and education, ensuring that employees can effectively utilize AI and digital modeling in their daily operations. Notably, Harald Schnidar and Avani Gupta from SCARLETRED highlighted how AI is transforming dermatological drug development by enhancing workflows while placing human expertise at the helm.
The Role of Digital Twins in Pharma Manufacturing
One of the focal points of the event was the concept of digital twins—virtual replicas of physical systems that improve productivity and efficiency. In a workshop led by Joachim Bär from Boehringer Ingelheim, participants learned how these models can help companies meet sustainability goals while optimizing their production processes. By simulating real-world conditions, digital twins facilitate better decision-making and minimize risks associated with drug development and manufacturing.
A Leap Towards Patient-Centric AI Solutions
Zisis Kozlakidis from the IARC/WHO provided insights into the importance of patient-centric digital interactions, showcasing how AI can bolster public health outcomes through enhanced data integration. By shifting focus to the patients' experiences, pharmaceutical companies can harness AI to craft more targeted interventions resulting in improved care.
Showcasing Innovations in Pharma at the Exhibition Zone
The exhibition showcased a variety of innovative tools and technologies. Noteworthy displays included Sapio Sciences’ LIMS platforms for laboratory data unification, Innowise's AI and machine learning services, and I-care’s asset performance and predictive maintenance software. These advancements illustrate the potential of digital solutions in streamlining the entire R&D and manufacturing continuum.
The Future of AI in Pharma Supply Chains
The discussions on the second day gravitated towards the intersection of AI and supply chain management. Cédric Colon from GSK elaborated on how digital transformation is unlocking greater value in supply chain logistics. This evolution is essential for increasing efficiency and ensuring compliance in an increasingly complex regulatory environment.
Conclusion: Preparing for AUTOMA+ 2026
As the dialogue progresses toward next year’s AUTOMA+ 2026, set for Zurich on November 16–17, the focus will remain on the promising interplay of digitalization, AI, and next-generation manufacturing processes. For leaders in the pharmaceutical industry, this ongoing evolution presents substantial opportunities to reshape operational strategies and adapt to get ahead in a highly competitive market.
By harnessing insights from events like AUTOMA+, professionals can ensure their organizations are not just participants in this revolution but leaders driving it forward. Now is the time to invest in digital skills and innovative technologies for a sustainable future in healthcare.
Add Row
Add
Write A Comment